Giuseppe Lippi/LinkedIn
Oct 20, 2026, 05:11
Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
Giuseppe Lippi, Professor at University of Verona, Dean at Faculty of Medicine and Surgery, shared a post in LinkedIn about a recent article he and his colleagues co-authored, published in Clinical Biochemistry, adding:
”Reframing liver test abnormalities after AAV gene therapy: a mechanistic diagnostic framework.”
Title: Reframing liver test abnormalities after AAV gene therapy: a mechanistic diagnostic framework
Authors: Brandon Michael Henry, Bernard Benichou, Melvin Y Rincon, Giuseppe Lippi, Lorenzo D’Antiga
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial